Evidence map›Paper›PMID 36103150›Full record

ArticleBlood advances2023

Soluble urokinase-type plasminogen activator receptor in sickle cell disease-associated chronic kidney disease.

Nowah Afangbedji, Namita Kumari, Sharmin Diaz, Fayuan Wen, James G Taylor, Sergei Nekhai, Marina Jerebtsova

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Management of Kidney Disease with Sickle Cell Disease.Journal of the American Society of Nephrology : JASN · 2025
    Review
  3. Article
  4. Article
  5. Sickle Cell Disease and CKD: An Update.American journal of nephrology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nowah AfangbedjiCenter for Sickle Cell Disease, College of Medicine, Howard University, Washington, DC.
Namita KumariCenter for Sickle Cell Disease, College of Medicine, Howard University, Washington, DC.ORCID 0000-0003-0893-9939
Sharmin DiazCenter for Sickle Cell Disease, College of Medicine, Howard University, Washington, DC.
Fayuan WenCenter for Sickle Cell Disease, College of Medicine, Howard University, Washington, DC.
James G TaylorCenter for Sickle Cell Disease, College of Medicine, Howard University, Washington, DC.ORCID 0000-0002-4421-1809
Sergei NekhaiCenter for Sickle Cell Disease, College of Medicine, Howard University, Washington, DC.ORCID 0000-0003-0744-7887
Marina JerebtsovaDepartment of Microbiology, College of Medicine, Howard University, Washington, DC.ORCID 0000-0001-7723-4954
Howard University · US

Funding

NHLBI Data Stage Coordinating CenterOT3HL147154 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ashok Kumar Krishnamurthy · 2018 to 2026
$98.9M
Sleep Disorders in Adults with Sickle Cell Disease: Frequency, Associations with Cardiovascular and Pain Indicators, and Responses to TreatmentU54MD007597 · NIMHD · HOWARD UNIVERSITY · PI Emily M Cramer · 2019 to 2026
$37.7M
SWG 2: Cure Research Scientific Working GroupP30AI117970 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI Italo Mocchetti · 2015 to 2026
$29.6M
Center for Hemoglobin Research in Minorities (CHaRM)P50HL118006 · NHLBI · HOWARD UNIVERSITY · PI NEKHAI, SERGEI · 2013 to 2017
$7.0M
Sickle Cell Disease and Sickle Cell Trait Protection Against HIV-1-infection in Africans and African AmericansR01HL125005 · NHLBI · HOWARD UNIVERSITY · PI MARINA A JEREBTSOVA, SERGEI NEKHAI · 2014 to 2026
$6.7M
The role of HGFL in the sickle cell disease nephropathySC1HL150685 · NHLBI · HOWARD UNIVERSITY · PI JEREBTSOVA, MARINA A · 2019 to 2022
$1.5M
NHLBI NIH HHS OT3 HL147154NHLBI NIH HHS P50 HL118006NHLBI NIH HHS R01 HL125005NHLBI NIH HHS SC1 HL150685NIAID NIH HHS P30 AI117970NIMHD NIH HHS U54 MD007597
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Receptors, Urokinase Plasminogen ActivatorRenal Insufficiency, ChronicHumansSignal TransductionReceptors, Urokinase Plasminogen Activator

Identifiers

PMID36103150
PMCPMC10165179
OpenAlexW4295759465

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.